<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To determine the role of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) and of <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> (RP) in the development of <z:hpo ids='HP_0002076'>migraine</z:hpo> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 50 unselected SLE patients and 20 <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA) controls underwent an interview to define the presence of <z:hpo ids='HP_0002076'>migraine</z:hpo> according to the guidelines of the International <z:hpo ids='HP_0002315'>Headache</z:hpo> Society (1988) </plain></SENT>
<SENT sid="2" pm="."><plain>Serological tests for aPL were performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>SLE patients were divided according to positivity for RP and/or aPL into 4 subsets: R-/aPL-, R-/aPL+, R+/aPL- and R+/aPL+ </plain></SENT>
<SENT sid="4" pm="."><plain>Data were analysed using Fisher's exact test, Chi-square test and U Mann-Whitney test </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: SLE and RA patients were similar for demographic and clinical features; aPL positivity was found in a greater proportion of SLE patients versus RA controls (68% vs 25%, p=0.0036) </plain></SENT>
<SENT sid="6" pm="."><plain>31 of the 50 lupic patients (62%) and 7 of the 20 RA controls (35%) suffered from <z:hpo ids='HP_0002076'>migraine</z:hpo> (OR=3, CI:1-8.9) </plain></SENT>
<SENT sid="7" pm="."><plain>Among SLE and RA patients, <z:hpo ids='HP_0002076'>migraine</z:hpo> was associated with aPL positivity (p=0.027 and p=0.019) </plain></SENT>
<SENT sid="8" pm="."><plain>Analysing the combined effect of aPL and RP on <z:hpo ids='HP_0002076'>migraine</z:hpo>, in R+/aPL+ patients we detected an higher frequency of <z:hpo ids='HP_0002076'>migraine</z:hpo> (85.7%) with respect to the patients negative for these two features (27%, p=0.0051, OR=16, CI:2.2-118) and to the patients positive only for aPL (65%, p=0.0031, OR=6.2, CI:1.2-32) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002076'>Migraine</z:hpo> in SLE and RA associates with aPL positivity </plain></SENT>
<SENT sid="10" pm="."><plain>The simultaneous presence of RP increases by 2,5 times the probability of having <z:hpo ids='HP_0002076'>migraine</z:hpo>, suggesting that <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> might be more common in patients with peripheral vasospasm, given the presence of aPL </plain></SENT>
</text></document>